Criteria For Dry Eye Research Articles

Efficacy of Isotonic Seawater Solution on Inflammation of the Ocular Surface in Matrix Metalloproteinase MMP-9-Positive Dry Eye Disease Patients

Purpose: Prospective study to evaluate the anti-inflammatory efficacy of isotonic seawater solution on metalloproteinase 9 (MMP-9) levels in the tears of patients with dry eye disease (DED). Methods: A total of 50 patients were included, with the following dry eye criteria in both eyes: InflammaDry? test initially positive, ocular surface disease index (OSDI) score ≥ 12 and Results: The InflammaDry test was positive in 100% of the patients (n = 50) and in 100% (n = 100) of the eyes before treatment. In 14 (28%) patients the test became negative in both eyes, and in 15 (30%) it was negative in one of the eyes. In 43% (n = 43) of the positive eyes, MMP-9 became undetectable in the tear fluid following treatment with isotonic seawater. This change was statistically significant (p Conclusions: The washes with ophthalmic isotonic seawater solution have a significant impact on inflammation of the ocular surface in dry eye disease, with an ability to make MMP-9 levels negative in 43% of cases.

Comparison of noncontact infrared and remote sensor thermometry in normal and dry eye patients.

To evaluate the role of closed chamber infrared and remote sensor thermometry in normal and dry eye patients. The study was conducted on 51 dry eye cases (102 eyes), 26 men and 25 women aged 19 to 65 years (35.3614.36), and 51 normal (102 eyes) age- and sex-matched control subjects. The criteria for dry eye were Schirm e r-1 (<10 m/5 min), FTBUT (<10 sec), nd lissamine green score (>2). The remote sensor and infrared thermometry was done in losed chamber around the eye in closed and open eye positions. In normal eyes, closed chamber infrared thermometry recorded temperature 34.770.37 C in closed eye position and 35.020.39 C in open eye position as compared to 27.912.46 C in closed eye position and 28.012.46 C in open position with remote sensor thermometry. The difference in temperature from closed to open position was 0.250.90 C in infrared thermometry and 0.100.00 C with remote sensor thermometry, which was statistically significant (p<0.0000). In dry eye, the infrared therm o m e t ry recorded 35.080.61 C temperature in closed eye position and 35.530.63 C in open eye position as compared to 27.412.48 C in open and closed eye position with remote sensor thermometry. The difference in temperature from closed to open eye position was 0.450.14 C (p<0.0000) with infrared thermometry as compared to no change 0.000.00 C with remote sensor thermometry (p<0.0000). Remote sensor thermometry proved better for diagnosis of dry eye disease as it showed no change in temperature under closed chamber in closed and open position (p=0.0000). Infrared thermometry was better in recording the absolute temperature from any point on the eye.

Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay

To measure matrix metalloproteinase 9 (MMP-9) in the tear film of patients with dry eye disease (DED) compared with controls and to correlate clinical findings. In a prospective study, 101 patients and controls underwent MMP-9 testing of the tear film. Thereafter, they were evaluated for symptoms and signs of DED. Included patients were those who showed 3 of the following 4 dry eye criteria: ocular surface disease index (OSDI) score of more than 12, tear film break-up time (TBUT) of 10 seconds or less, Schirmer test results without anesthesia of less than 10 mm/5 minutes, and corneal staining results of 1 or more. Fifty-four healthy eyes and 47 eyes fulfilling diagnostic criteria for DED of various levels of severity were included in this study. The tear film was analyzed for MMP-9 by a commercially available test (InflammaDry; Rapid Pathogen Screening, Inc, Sarasota, FL) detecting MMP-9 levels of more than 40 ng/ml. Symptoms and signs of DED were evaluated using the OSDI questionnaire, TBUT, conjunctival and corneal staining, Schirmer test results without anesthesia, and meibomian gland examination. These findings were correlated to results of the MMP-9 test in tears. Positive MMP-9 results in tears. In 19 of 47 patients confirmed with dry eye (40.4%) and in 3 of 54 controls (5.6%), the MMP-9 results were positive. This difference was statistically significant (P < 0.001). Thus, the MMP-9 results indicated a clinically significant inflammation in 40% of dry eye patients. Positive results correlated well with subjective symptoms of DED evaluated by OSDI (P= 0.001), TBUT of less than 5 seconds (P < 0.013), Schirmer test results (P < 0.001), conjunctival staining (P < 0.001), and corneal staining (P= 0.007). Moreover, MMP-9 results correlated with the number of obstructed meibomian ducts (P= 0.005) and a pathologic meibomian gland secretion (P= 0.001). The MMP-9 results were increased significantly in women (P < 0.001) and in patients with autoimmune disease (P= 0.005), especially Sjögren's syndrome (P= 0.001) and thyroid disease (P= 0.012). Matrix metalloproteinase 9 testing in DED is a valuable new diagnostic tool. It correlated well with other dry eye tests and identified the presence of ocular surface inflammation in 40% of confirmed dry eyepatients. It may be especially helpful to identify patients with ocular surface inflammation and autoimmune disease and may facilitate the decision to institute anti-inflammatory treatment in these patients.

Dry eye disease in French elderly subjects: the Alienor Study

To describe dry eye disease in French elderly subjects. The Alienor Study is a population-based study on age-related eye disease in 963 residents of Bordeaux (France), aged 73 years or more. Self-reported dry eye disease and use of artificial tears were documented through face-to-face interview. Dry eye symptoms were assessed using the Ocular Surface Disease Index (OSDI) questionnaire and tear film stability by tear break-up time measurements (TBUT). Definite dry eye disease was defined as self-reported dry eye, confirmed by use of artificial tears and/or OSDI greater or equal to 22. Nine hundred and fifteen subjects, with mean age of 80 ± 4 years, returned the OSDI questionnaire. Of these, 271 (29.6%) subjects reported a dry eye disease and 135 (14.7%) were using artificial tears. An OSDI score > 22 was found in 359 (39.2%) subjects and a TBUT < 5 seconds in 335/746 (44.9%) subjects. Overall, definite dry eye affected 21.9% of subjects and was more frequent in women (27.1%) than in men (13.6%). After multivariate adjustment, dry eye disease was also significantly less frequent in subjects with high educational level (odds ratio (OR) = 0.49, 95% confidence interval (CI): 0.31-0.78 for long secondary school) and more frequent in subjects with ocular hypertension (OR = 1.61, 95% CI: 1.02-2.57) and those using anxiolytics (OR = 1.53, 95% CI: 1.02-2.29). This large observational study confirmed the high prevalence of dry eye symptoms among elderly subjects and confirmed some of the previously identified risk factors (in particular female gender and use of anxiolytics).

Comparison of Noncontact Infrared and Remote Sensor Thermometry in Normal and Dry Eye Patients

To evaluate the role of closed chamber infrared and remote sensor thermometry in normal and dry eye patients. The study was conducted on 51 dry eye cases (102 eyes), 26 men and 25 women aged 19 to 65 years (35.36+/-14.36), and 51 normal (102 eyes) age- and sex-matched control subjects. The criteria for dry eye were Schirmer-1 (<10 m/5 min), FTBUT (<10 sec), nd lissamine green score (>2). The remote sensor and infrared thermometry was done in closed chamber around the eye in closed and open eye positions. In normal eyes, closed chamber infrared thermometry recorded temperature 34.77+/-0.37 degrees C in closed eye position and 35.02+/-0.39 degrees C in open eye position as compared to 27.91+/-2.46 degrees C in closed eye position and 28.01+/-2.46 degrees C in open position with remote sensor thermometry. The difference in temperature from closed to open position was 0.25+/-0.90 degrees C in infrared thermometry and 0.10+/-0.00 degrees C with remote sensor thermometry, which was statistically significant (p<0.0000). In dry eye, the infrared thermometry recorded 35.08+/-0.61 degrees C temperature in closed eye position and 35.53+/-0.63 degrees C in open eye position as compared to 27.41+/-2.48 degrees C in open and closed eye position with remote sensor thermometry. The difference in temperature from closed to open eye position was 0.45+/-0.14 degrees C (p<0.0000) with infrared thermometry as compared to no change 0.00+/-0.00 degrees C with remote sensor thermometry (p<0.0000). Remote sensor thermometry proved better for diagnosis of dry eye disease as it showed no change in temperature under closed chamber in closed and open position (p=0.0000). Infrared thermometry was better in recording the absolute temperature from any point on the eye.

Mucin and Leukocyte Interactions In Vitro

To measure matrix metalloproteinase 9 (MMP-9) in the tear film of patients with dry eye disease (DED) compared with controls and to correlate clinical findings.In a prospective study, 101 patients and controls underwent MMP-9 testing of the tear film. Thereafter, they were evaluated for symptoms and signs of DED.Included patients were those who showed 3 of the following 4 dry eye criteria: ocular surface disease index (OSDI) score of more than 12, tear film break-up time (TBUT) of 10 seconds or less, Schirmer test results without anesthesia of less than 10 mm/5 minutes, and corneal staining results of 1 or more. Fifty-four healthy eyes and 47 eyes fulfilling diagnostic criteria for DED of various levels of severity were included in this study.The tear film was analyzed for MMP-9 by a commercially available test (InflammaDry; Rapid Pathogen Screening, Inc, Sarasota, FL) detecting MMP-9 levels of more than 40 ng/ml. Symptoms and signs of DED were evaluated using the OSDI questionnaire, TBUT, conjunctival and corneal staining, Schirmer test results without anesthesia, and meibomian gland examination. These findings were correlated to results of the MMP-9 test in tears.Positive MMP-9 results in tears.In 19 of 47 patients confirmed with dry eye (40.4%) and in 3 of 54 controls (5.6%), the MMP-9 results were positive. This difference was statistically significant (P < 0.001). Thus, the MMP-9 results indicated a clinically significant inflammation in 40% of dry eye patients. Positive results correlated well with subjective symptoms of DED evaluated by OSDI (P = 0.001), TBUT of less than 5 seconds (P < 0.013), Schirmer test results (P < 0.001), conjunctival staining (P < 0.001), and corneal staining (P = 0.007). Moreover, MMP-9 results correlated with the number of obstructed meibomian ducts (P = 0.005) and a pathologic meibomian gland secretion (P = 0.001). The MMP-9 results were increased significantly in women (P < 0.001) and in patients with autoimmune disease (P = 0.005), especially Sjögren's syndrome (P = 0.001) and thyroid disease (P = 0.012).Matrix metalloproteinase 9 testing in DED is a valuable new diagnostic tool. It correlated well with other dry eye tests and identified the presence of ocular surface inflammation in 40% of confirmed dry eye patients. It may be especially helpful to identify patients with ocular surface inflammation and autoimmune disease and may facilitate the decision to institute anti-inflammatory treatment in these patients.